Kymriah: England Becomes First In Europe To Say Yes To CAR-T
A new deal between Novartis and England’s National Health Service is one of the fastest funding approvals in the 70-year history of the NHS.

A new deal between Novartis and England’s National Health Service is one of the fastest funding approvals in the 70-year history of the NHS.